BUZZ-3M India shares fall to 19-month low due to quarterly profit decline
路透社2026/11/06 07:56November 6 - ** Shares of 3M India (TMIN.NS) fell nearly 10% to 26,410 rupees, marking their lowest level since early April 2025
** The India subsidiary of US-based 3M MMM.N stated that although revenue grew by about 15%, second quarter post-tax profit (link) declined 17.2% year-on-year to 1.58 billion rupees (about $16.78 million)
** The company stated that the drop in profit was due to the depreciation of the Indian rupee and input cost inflation caused by the Middle East crisis
** So far this year, the share price has dropped nearly 23%
(1 USD = 94.1550 Indian rupees)
(For the convenience of non-English speakers, Reuters has automated its reports into several other languages. As automated translation may have errors or lack required context, Reuters does not guarantee the accuracy of automated translation texts and provides them solely for reader convenience. Reuters assumes no responsibility for any harm or loss arising from the use of automated translation features.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment
According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.
GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions
Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.
Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.
After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.
Hong Kong live music service provider Guitar Group applies for US IPO, aiming to raise $31 million
Guitar Group, a provider of music performance events, guitar-making workshops, and guitar repair services, submitted an application to the U.S. Securities and Exchange Commission (SEC) on Thursday, seeking to raise up to $31 million through an initial public offering (IPO).
Crypto prices
More
